However, in cancer cells, whereas some reports show evidence for post-transcriptional down-regulation of BCL-2 (e.g., [154,155]), others demonstrate an overproduction of the Bcl-2 protein on the basis on increased BCL-2 mRNA levels (e.g. [156,157]). The gene discussed is BCL2; the disease is cancer.